This test was developed and its performance characteristics determined by Marshfield Labs. It has not been cleared or approved by the US Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research.
The sensitivity of PCR for the diagnosis of Borrelia burgdorferi infection is variable depending on the stage of the disease and presence or absence of prior antimicrobial therapy. A negative result does not exclude active infection. PCR results should be interpreted in conjunction with all of the clinical, laboratory, and epidemiologic information that is available.
PCR on CSF is only available as a send out. Order MISC and comment LYMPV.